Newell Joe 4
4 · Atara Biotherapeutics, Inc. · Filed Mar 30, 2021
Insider Transaction Report
Form 4
Newell Joe
Chief Tech. Operations Officer
Transactions
- Sale
Common Stock
2021-03-26$14.58/sh−2,640$38,491→ 135,579 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).
- [F2]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $14.437 to $14.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.